- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Tenaya Therapeutics Inc (TNYA)
Tenaya Therapeutics Inc stock price live, this page displays NASDAQ TNYA stock exchange data. View the TNYA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Tenaya Therapeutics Inc real time stock price chart below.
What Is the Tenaya Therapeutics Inc Stock Price Today?
The Tenaya Therapeutics Inc stock price today is 0.766.
What Is the Stock Symbol for Tenaya Therapeutics Inc?
The stock ticker symbol for Tenaya Therapeutics Inc is TNYA.
Is TNYA the Same as $TNYA?
$TNYA is a common way to refer to the Tenaya Therapeutics Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Tenaya Therapeutics Inc Trade On?
Tenaya Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Tenaya Therapeutics Inc a Good Stock to Buy?
Determining whether Tenaya Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Tenaya Therapeutics Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TNYA quote. (ISIN: US87990A1060)
What Is the Tenaya Therapeutics Inc Stock Price Today?
The Tenaya Therapeutics Inc stock price today is 0.766.
What Is the Stock Symbol for Tenaya Therapeutics Inc?
The stock ticker symbol for Tenaya Therapeutics Inc is TNYA.
Is TNYA the Same as $TNYA?
$TNYA is a common way to refer to the Tenaya Therapeutics Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Tenaya Therapeutics Inc Trade On?
Tenaya Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Tenaya Therapeutics Inc a Good Stock to Buy?
Determining whether Tenaya Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Tenaya Therapeutics Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TNYA quote. (ISIN: US87990A1060)
0.766
+0.027(+3.59%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.730
0.770
52 wk Range
0.360
2.350
TNYA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.7300.770
52 wk Range
0.3602.350
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
TNYA Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
9.000
Upside
+1,074.93%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
3 analysts have revised their earnings upwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. Its lead product candidate includes TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy that is in Phase 1b/2 clinical trial; TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy, which is in Phase 1b/2 clinical trial; and TN-301, a small molecule histone deacetylase-6 for heart failure with preserved ejection fraction that is in phase 1 clinical trial. The company develops its products through gene addition, gene editing, gene silencing, and cellular regeneration. It has a research collaboration agreement with Alnylam Pharmaceuticals, Inc. to identify and validate novel gene targets for the potential treatment of cardiovascular disease. Tenaya Therapeutics, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.
Tenaya Therapeutics Inc SWOT Analysis
Risks and Rewards | Delve into Tenaya's SWOT analysis, balancing its pioneering status against clinical uncertainties and fierce competition in the evolving gene therapy landscape |
Market Potential | Analyst consensus suggests significant upside, with price targets ranging from $8 to $40, reflecting high expectations for Tenaya's pipeline |
Clinical Milestones | Explore the pivotal MyPEAK-1 and RIDGE-1 trials, set to deliver crucial data in 2024, potentially validating Tenaya's innovative approach |
Gene Therapy Pionee | Tenaya Therapeutics leads in cardiac gene therapy, with TN-201 poised to be the first treatment for MYBPC3-related hypertrophic cardiomyopathy |
Compare TNYA to Peers and Sector
Metrics to compare | TNYA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTNYAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.8x | −3.6x | −0.5x | |
PEG Ratio | −0.03 | −0.11 | 0.00 | |
Price / Book | 1.3x | 4.9x | 2.6x | |
Price / LTM Sales | - | 17.6x | 3.2x | |
Upside (Analyst Target) | 308.7% | 92.8% | 47.6% | |
Fair Value Upside | Unlock | 1.3% | 6.1% | Unlock |
Analyst Ratings
8 Buy
0 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 9.000
(+1,074.93% Upside)
Earnings
Latest Release
Mar 11, 2026
EPS / Forecast
-0.12 / -0.12
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Tenaya Therapeutics (TNYA) Stock Price Today?
The Tenaya Therapeutics stock price today is 0.766 USD.
What Stock Exchange Does Tenaya Therapeutics Trade On?
Tenaya Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Tenaya Therapeutics?
The stock symbol for Tenaya Therapeutics is "TNYA."
What Is the Tenaya Therapeutics Market Cap?
As of today, Tenaya Therapeutics market cap is 164.920M USD.
What Is Tenaya Therapeutics's Earnings Per Share (TTM)?
The Tenaya Therapeutics EPS (TTM) is -0.592.
When Is the Next Tenaya Therapeutics Earnings Date?
Tenaya Therapeutics will release its next earnings report on May 13, 2026.
From a Technical Analysis Perspective, Is TNYA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Tenaya Therapeutics Stock Split?
Tenaya Therapeutics has split 0 times.
How Many Employees Does Tenaya Therapeutics Have?
Tenaya Therapeutics has 70 employees.
What is the current trading status of Tenaya Therapeutics (TNYA)?
As of Apr 15, 2026, Tenaya Therapeutics (TNYA) is trading at a price of 0.766 USD, with a previous close of 0.739 USD. The stock has fluctuated within a day range of 0.730 USD to 0.770 USD, while its 52-week range spans from 0.360 USD to 2.350 USD.
What Is Tenaya Therapeutics (TNYA) Price Target According to Analysts?
The average 12-month price target for Tenaya Therapeutics is 9.000 USD, with a high estimate of 40 USD and a low estimate of 2 USD. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +1,074.93% Upside potential.
What Is the TNYA Premarket Price?
TNYA's last pre-market stock price is 0.745 USD. The pre-market share volume is 72,540.000, and the stock has decreased by 0.006, or 0.810%.
What Is the TNYA After Hours Price?
TNYA's last after hours stock price is 0.758 USD, the stock has decreased by 0.019, or 2.570%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.